| Application no. and date | 20191747.3 (espacenet) (Federated) (European Patent Register), 20150309 | | Patent/reg. no. and date | DK/EP 3828173, 20220831 | | Publication date | 20210602 | | Priority no. and date | US 201461949808 P, 20140307, US 201461981515 P, 20140418 | | EP pub. no. and date |
EP 3828173 20210602 | | Effective date | | | Applicant/owner | BioCryst Pharmaceuticals,
Inc., 4505 Emperor Blvd.
Durham, NC 27703, US | | Applicant ref. no. | 167050/BTCB | | Inventor | ZHANG, Weihe, 2645 Manchester Court
Vestavia, Alabama 35226, US,
KOTIAN, Pravin L., 1139 Magnolia Run
Hoover, Alabama 35226, US,
BABU, Yarlagadda S., 4836 Southlake Pkwy
Birmingham, Alabama 35244, US,
WU, Minwan, 2709 Paden Trl
Vestavia Hills, Alabama 35226, US,
CHINTAREDDY, Venkat R, 3134 Renfro Road
Vestavia Hills, Alabama 35216, US,
KUMAR, Satish V, 809 Mayapple Ct
Birmingham, Alabama 35244, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/415 (2006.01) , C07D 231/14 (2006.01) | | Title | SUBSTITUEREDE PYRAZOLER SOM HUMANT PLASMA-KALLIKREININHIBITORER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
